COVID-19 Pfizer Information


X

Thanks for finding us at AUA 2022

Who We Are and What We Do

​​​​​​​One way or another, cancer touches all of our lives. That is why nothing is more personal, or more urgent, than our goal to find new treatments for these deadly diseases


Thanks for finding us at AUA 2022

Who We Are and What We Do

​​​​​​​One way or another, cancer touches all of our lives. That is why nothing is more personal, or more urgent, than our goal to find new treatments for these deadly diseases

Product Theater

Elevate Care in Advanced Prostate Cancer
​​​​​​​
Location: Science and Technology Hall in ICU Theater, Booth 1043

Session Date and Time: Friday, May 13, 2022, 12:00pm - 1:00pm

Speaker: Dr. Ken Kernen

Add To CalendarInvite

Exploring Clinical Evidence of a Treatment Option for Metastatic Castration-Sensitive Prostate Cancer

​​​​​​​Location: Science and Technology Hall in ICU Theater, Booth 1043

Session Date and Time: Saturday, May 14, 2022, 12:00pm - 1:00pm
​​​​​​​
Speaker: Dr. David Crawford

Add To CalendarInvite

An Oral Treatment Option for Advanced Prostate Cancer

Location: Great Hall B

Session Date and Time: Sunday, May 15, 2022, 7:00am - 8:00am

​​​​​​​Speaker: Dr. Ashley Ross

Add To CalendarInvite

Oral Presentations

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Long-Term Follow-Up Results From the JAVELIN Bladder 100 Trial (Encore)
​​​​​​​
Location: Ernest N. Morial Convention Center, Room 225
 
Date and Time: Friday, May 13, 2022; 1:00 PM - 3:00 PM

Add To Calendar

Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer: Detailed Pooled Safety Analyses from Randomized Controlled Studies
 
Location: Ernest N. Morial Convention Center, Room 252

Date and Time: Sunday, May 15, 2022 7:00 AM - 9:00 AM

Add To Calendar

Highlights From Your Congress



pfizer
Tile-1

Product Theater

Elevate Care in Advanced Prostate Cancer
​​​​​​​
Location: Science and Technology Hall in ICU Theater, Booth 1043

Session Date and Time: Friday, May 13, 2022, 12:00pm - 1:00pm

Speaker: Dr. Ken Kernen

Add To CalendarInvite

Exploring Clinical Evidence of a Treatment Option for Metastatic Castration-Sensitive Prostate Cancer

Location: Science and Technology Hall in ICU Theater, Booth 1043

Session Date and Time: Saturday, May 14, 2022, 12:00pm - 1:00pm
​​​​​​​
Speaker: Dr. David Crawford

Add To CalendarInvite

An Oral Treatment Option for Advanced Prostate Cancer

Location: Great Hall B

Session Date and Time: Sunday, May 15, 2022, 7:00am - 8:00am
​​​​​​​
Speaker: Dr. Ashley Ross

Add To CalendarInvite

What’s Of Interest


Tile-1
Tile-2

Patient Education for HCPs

Tile-3
Tile-4

Tile-5
Tile-6

Quality Improvement Resources for HCPs

Tile-1

Tile-4

Competitive Grants

Tile-7

Get It Done - Cancer Screening Campaign

Tile-1
Tile-2
Tile-3
Tile-4
Tile-8

Pfizer Oncology Collaborating to Improve Patient Centricity


Commitment To Oncology


Tile-8

Supporting Our Patients

Scheduled Events

Product Theater


Elevate Care in Advanced Prostate Cancer

Location: Science and Technology Hall in ICU Theater, Booth 1043

Session Date and Time:
Friday, May 13, 2022, 12:00pm - 1:00pm
​​​​​​​
Speaker: Dr. Ken Kernen

Add to Calendar


Exploring Clinical Evidence of a Treatment Option for Metastatic Castration-Sensitive Prostate Cancer

Location: Science and Technology Hall in ICU Theater, Booth 1043

Session Date and Time:
Saturday, May 14, 2022
12:00pm - 1:00pm
​​​​​​​
Speaker: Dr. David Crawford
​​​​​​​

Add to Calendar


An Oral Treatment Option for Advanced Prostate Cancer

Location: Great Hall B

Session Date and Time:
Sunday, May 15, 2022
7:00am - 8:00am
​​​​​​​
Speaker: Dr. Ashley Ross
​​​​​​​

Add to Calendar


​​​​​​​Oral Presentations


Presentation Title: Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Long-Term Follow-Up Results From the JAVELIN Bladder 100 Trial (Encore)

Location: Ernest N. Morial Convention Center, Room 225
​​​​​​​
Presentation Date and Time: Friday, May 13, 2022; 1:00 PM - 3:00 PM CDT
​​​​​​​

Add to Calendar


Presentation Title: Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer: Detailed Pooled Safety Analyses from Randomized Controlled Studies

Location: Ernest N. Morial Convention Center, Room 252
​​​​​​​
Presentation Date and Time: Sunday, May 15, 2022, 7:00 AM - 9:00 AM CDT
​​​​​​​

Add to Calendar


​​​​​​​Poster Presentations


Presentation Title: Overall Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer Treated with Enzalutamide or Placebo Plus Androgen Deprivation Therapy Who Had Prior Local Therapy: Post Hoc Analysis of the Phase 3 ARCHES Trial

Location: Room 222
​​​​​​​
Presentation Date and Time: Saturday, May 14, 2022, 10:30am–11:45am CDT
​​​​​​​

Add to Calendar


Presentation Title: Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer:
Detailed Safety Analysis from the Randomized Phase 3 HERO Study

Location: Room 222
​​​​​​​
Presentation Date and Time: Saturday, May 14, 2022, 10:30am–11:45am CDT
​​​​​​​

Add to Calendar


Presentation Title: Evaluating Cardiovascular Risk in Men Starting Androgen Deprivation Therapy for Prostate Cancer

Location: Room 222
​​​​​​​
Presentation Date and Time: Sunday, May 15 2022, 2:45pm - 4:00pm CDT
​​​​​​​

Add to Calendar

X

X

PF-06863135 is an investigational compound and has not been approved by any Regulatory Authority as safe or effective for any use. The preclinical and in vitro evidence presented here may not necessarily correlate with clinical outcomes.